SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 5th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 30, 2020, between Wize Pharma, Inc., a Delaware corporation (the “Company”), and the purchasers set forth on the signature pages affixed hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • January 5th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [●] [●], 2021 (this “Agreement”), is entered into by and among Wize Pharma, Inc., a Delaware corporation (the “Company,” or “Wize”), Cosmos Capital Limited (ACN 636 458 912), an Australian company (“Cosmos”), [●], Inc., a Delaware corporation and a wholly owned subsidiary of the Company ("Wize US"), OcuWize Ltd., a company incorporated under the laws of the state of Israel and a wholly owned subsidiary of Wize US (“OcuWize”), [_______], as the Holders’ Representative (as defined herein), [●], as Rights Agent (the “Rights Agent”) and as initial CVR Registrar (as defined herein).
WARRANT AGENCY AGREEMENTWarrant Agency Agreement • January 5th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations • New York
THIS WARRANT AGENCY AGREEMENT (this “Agreement”) dated as of [●] [●], 2021, between WIZE PHARMA, INC., a Delaware corporation, with offices at 24 Hanagar Street, Hod Hasharon, Israel (the “Company”), and [●], a [●] corporation, with offices at [●], as warrant agent (the “Agent”).
Bid Implementation AgreementBid Implementation Agreement • January 5th, 2021 • Wize Pharma, Inc. • Pharmaceutical preparations
